Price Alert

Pulmonx Corporation (LUNG)

NASDAQ: LUNG · Real-Time Price · USD

1.52

-0.08 (-5.00%)

At close: Aug 19, 2025, 12:11 PM

-5.00% (1D)

Bid	1.52
Market Cap	62.14M
Revenue (ttm)	90.55M
Net Income (ttm)	-56.94M
EPS (ttm)	-1.43
PE Ratio (ttm)	-1.07
Forward PE	-1.18
Analyst	Buy

Ask	1.53
Volume	278,073
Avg. Volume (20D)	583,259
Open	1.60
Previous Close	1.60
Day's Range	1.52 - 1.61
52-Week Range	1.47 - 9.37
Beta	0.43

About LUNG

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LUNG

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for LUNG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Pulmonx Corporation is scheduled to release its earnings on Oct 29, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

-41.59%

Pulmonx shares are trading lower after the company... Unlock content with Pro Subscription

2 weeks ago

+1.94%

Pulmonx shares are trading lower after the company reported Q2 financial results and cut its FY25 sales guidance below estimates.

News

1 week ago · zacks.com

After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG)

Pulmonx (LUNG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates c...

2 weeks ago · seekingalpha.com

Pulmonx Corporation (LUNG) Q2 2025 Earnings Call Transcript

Pulmonx Corporation (NASDAQ:LUNG ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 AM ET Company Participants Mehul Joshi - Chief Financial Officer Steven S. Williamson - CEO, President & Director...

2 weeks ago · zacks.com

Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates

Pulmonx Corporation (LUNG) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.4. This compares to a loss of $0.39 per share a year ago.